0001493152-22-003030.txt : 20220202 0001493152-22-003030.hdr.sgml : 20220202 20220202190851 ACCESSION NUMBER: 0001493152-22-003030 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220201 FILED AS OF DATE: 20220202 DATE AS OF CHANGE: 20220202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Litchev Boyan Vesselinov CENTRAL INDEX KEY: 0001902726 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40652 FILM NUMBER: 22585499 MAIL ADDRESS: STREET 1: 13357 RUSSET LEAF LN. CITY: SAN DIEGO STATE: CA ZIP: 92129 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Indaptus Therapeutics, Inc. CENTRAL INDEX KEY: 0001857044 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 863158720 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 COLUMBUS CIRCLE STREET 2: 15TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 347-480-9760 MAIL ADDRESS: STREET 1: 3 COLUMBUS CIRCLE STREET 2: 15TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: Intec Parent Inc. DATE OF NAME CHANGE: 20210414 4 1 ownership.xml X0306 4 2022-02-01 0 0001857044 Indaptus Therapeutics, Inc. INDP 0001902726 Litchev Boyan Vesselinov C/O INDAPTUS THERAPEUTICS, INC. 3 COLUMBUS CIRCLE, 15TH FLOOR NEW YORK NY 10019 0 1 0 0 Chief Medical Officer Stock Option (right to buy) 4.97 2022-02-01 4 A 0 90000 0 A 2032-02-01 Common Stock 90000 90000 D The stock option vests and becomes exercisable as to one-third of the total shares on February 1, 2023 and thereafter the remaining shares vest and become exercisable in equal monthly installments over the following 24 months. /s/ Boyan Litchev 2022-02-02